Responses
Regular and Young Investigator Award Abstracts
Novel Single-Agent Immunotherapies
1339 Systemically administered onco-selective mRNA LNP achieves tumor regression and improves overall survival, as monotherapy
Compose a Response to This Article
Other responses
No responses have been published for this article.
